Search results for: 'manag fuel develop deceleration'

This market engineering research service has been developed to address the advanced wound management in Taiwan. This research service presents the key findings of market. It provides insights and forecast of market size, overview, and strategic recommendations. This research service also discusses market trends, market drivers, and market restraint...

This research service presents the key findings of end users research conducted in 2007 for the Australian Wound Care Management Market. It provides insights of end-users preferred products and brands for different types of wound care. End -users' perceived product benefits and satisfaction towards products used were included. It also discussed the...

In this first Customer Experience Management report for Malaysias Medical Insurance industry, Frost & Sullivan explores the relationship of the experiences provided by medical insurance companies for its customers. We look at the critical factors that influence customer behaviours throughout the three phases (pre-purchase, purchase and post-purcha...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At AU...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

A market outlook of the Cardiac Rhythm Management Devices covering China, Hong Kong, South Korea and Malaysia. This study includes the market drivers, restraints and forecasting for the pacemaker, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices and CRM leads. The forecast period of the study is from 2...

This research service covers the revenues and trends in the Asia-Pacific (APAC) image-guided surgery (IGS) and robot-assisted surgery (RAS) market. Higher disposable income, penetration of health insurance, and improvement in overall quality of life necessitate the need for quality healthcare services. This has led to investment in assistive techno...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...